← Skin Intelligence Digest
Emergingingredients
I’ve Finally Found Sunscreens for Oily Skin That Actually Stay Shine-Free
Published June 12, 20261 min read
Intelligence brief
Save this story Save Story Save this story As someone in the oily-skin community, finding products I trust, especially ones I have to use multiple times a day can feel surprisingly tricky. While there are plenty of skin-care brands catering to oily and acne-prone skin, sunscreen remains one of the most difficult categories to get right, particularly when it comes to textures that don’t clog pores or feel greasy once applied. Key Ingredients : 5% Niacinamide Chemical or Mineral: Hybrid (Zinc Oxide 9%, Octinoxate 7.5%) SPF Level: SPF 46 Broad-Spectrum : Yes Oil-Free: Yes Finish : Natural Best Mineral : U Beauty Multimodal Sheer Mineral Sunscreen Save to wishlist Save to wishlist U Beauty As it relates to sunscreens for oily skin, we selected the best based on the following characteristics: ingredients, texture, finish, SPF level, UV filters, broad-spectrum coverage, and the skin-care concerns they address. To do this, we paired our own personal tests of each formula with expert guidance and reviewer insights to determine which we would recommend to you. Read more about our testing methodology here .
Key signals
- For oily skin typesWatch this signal for how it shapes shine protocols and ingredient prioritisation.
- Ingredient signalCoverage centres on niacinamide, pay attention to concentration, vehicle, and pairings in your routine before changing anything material.
- Protocol implicationIf you actively address shine, this is a data point worth logging, not a directive to change the protocol on its own.
Ingredients referenced
Relevant concerns
shine
Related research in the vault
ingredientsRCT
Evaluation of Nicotinamide Riboside in Prevention of Small Nerve Fiber Axon Degeneration and Promotion of Nerve Regeneration.
J Peripher Nerv Syst · Mar 2026
Recent preclinical studies have shown that nicotinamide adenine dinucleotide (NAD+) plays a critical role in molecular mechanisms of axon degeneration, and reductions in NAD+ levels are associated with axonal degeneration. Nicotinamide riboside (NR) is a safe and widely available pyridine-nucleoside form of vitamin B3 and is an NAD+ precursor. To investigate if oral supplementation of synthetic NR can act as a therapeutic agent to prevent degeneration of small somatic sensory axons innervating the skin or promote regeneration of these same fibers in humans, we utilized a validated experimental model of cutaneous nerve degeneration and regeneration and conducted a placebo-controlled, double-blinded Phase 2 study.
niacinamidepharct
Read →ingredientsRCT
Changes in ultraviolet a radiation-induced thymidine dimers and erythema after oral nicotinamide or polypodium leucotomos extract in healthy volunteers: a randomized intraindividual trial.
Photochem Photobiol Sci · May 2026
Nicotinamide (NAM) and Polypodium leucotomos extract (PL) have demonstrated photoprotective effects, but their role in preventing UVA-induced DNA damage in humans remains unclear. To evaluate the effects of oral NAM and PL on UVA-induced erythema and thymidine dimer (TT-dimer) formation. In this intraindividual trial, 50 healthy volunteers (phototypes I-III) were randomized (1:1) to receive either NAM (2000 mg daily) or PL (Heliocare Advanced: 480 mg daily) for 30 days.
niacinamidepharosacea
Read →ingredientsRCT
Safety and efficacy of individualised exercise and NAD(+) precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.
Lancet Neurol · May 2026
Friedreich's ataxia is a rare, chronic, progressive, neurodegenerative condition affecting multiple organ systems, including neurological, musculoskeletal, cardiac, and endocrine systems, and is marked by low cardiopulmonary fitness. We tested the effect of exercise and NAD+ precursor supplementation with nicotinamide riboside, which have each shown benefits in animal and early clinical studies, on cardiopulmonary fitness in individuals with Friedreich's ataxia. This 12-week, outpatient, phase 2, single-site (Children's Hospital of Philadelphia, Philadelphia, PA, USA), randomised, 2 × 2 factorial clinical trial recruited individuals aged 10-40 years with an ejection fraction of 45% or greater who were able to exercise.
niacinamidepharct
Read →This intelligence brief synthesizes reporting from beauty and dermatology industry publications.
View source →